Medicare Clinical Trial Policy May Improve Outcomes Data - HHS Panelist
Executive Summary
Coverage of clinical trial costs under Medicare may lead to improved data for policy makers seeking to assess therapeutic outcomes in the elderly, Bruce Stuart, PhD, University of Maryland, suggested during the Aug. 8-9 HHS drug pricing conference in Washington, D.C.